Your session is about to expire
← Back to Search
Digital Acceptance and Commitment Therapy (ACT) Arm for Fibromyalgia (PROSPER-FM Trial)
PROSPER-FM Trial Summary
This trial is testing two different digital therapies to see if they help improve fibromyalgia symptoms. The main ways they will measure this is by looking at participants' responses to surveys about their symptoms and how they are doing overall.
- Fibromyalgia
PROSPER-FM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PROSPER-FM Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this clinical study open to participants of 40 years and above?
"In line with this trial's guidelines, the lowest age accepted for participation is 22 and the highest age permissible is 75."
Are there multiple research sites within the U.S. that are actively conducting this clinical trial?
"As of now, 25 different medical sites are signing up patients for this trial. These include Site #24 in Ocean Springs, Site #38 in Thousand Oaks, and Site #36 in Tujunga plus an additional 22 other locations."
Is it possible for me to register as a participant in this research program?
"This study requires 300 participants, aged between 22 and 75 that are diagnosed with fibromyalgia according to the 2016 American College of Rheumatology's Preliminary Diagnostic Criteria. Furthermore, all individuals must be able to read and comprehend English as well as have been on a stable course of treatment for 30 days prior to screening appointment in order to qualify."
Is there an ongoing recruitment of participants for this research trial?
"As indicated on clinicaltrials.gov, this research is currently recruiting patients. It was first published on February 8th 2022 and the last update occured October 14th of that same year."
How many participants are in the current clinical trial?
"Yes, indeed. According to clinicaltrials.gov information, this medical trial is presently recruiting participants - with a total of 300 persons sought across 25 different sites. The study was first posted on February 8th 2022 and the most recent update occurred on October 14th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Most responsive sites:
- Site #35: < 24 hours
Typically responds via
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger